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Abstract
Objective—To examine the incidence of single or multiple organ failure postburn and its 
resultant clinical outcomes during acute hospitalization.
Summary Background Data—Patient outcomes are inherently dependent on intact organ 
function; however, burn injury affects the structure and function of almost every organ, but 
especially lung, liver, kidney and heart. Therefore, single-organ failure and/or multiorgan failure 
(MOF) are thought to contribute significantly to postburn morbidity and mortality but to date no 
large trial examining the effects of MOF on postburn outcomes exists.
Methods—Incidence of MOF was monitored in 821 pediatric burn patients during acute 
hospitalization. Patients were divided into groups based on the incidence of single organ specific 
failure, MOF, and non-MOF. The DENVER2 score was used to assess organ specific scores for 
lung, liver, kidney and heart. The patient’s demographics, injury characteristics, and outcome 
parameters were recorded.
Results—Respiratory failure has the highest incidence in the early phase of postburn injury, and 
decreases starting 5 days postburn. Cardiac failure was noted to have the highest incidence 
throughout hospital stay. Incidence of hepatic failure increases with the length of hospital stay and 
is associated with a high mortality during the late phase of the acute hospital stay. Renal failure 
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has an unexpectedly low incidence but is associated with a high mortality during the first three 
weeks postburn injury. Three or more organ failure is associated with very high mortality.
Conclusion—This is the first large study in burn patients to determine the incidence of organ 
specific failure and outcome. The results of this study confirmed the expected chronologic 
incidence of organ-specific failure and yield the long-term mortality of liver and renal failure. 
(NCT00673309)
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INTRODUCTION
Intact organ function is essential for positive outcome of burn patients; however, burn injury 
affects the structure and function of almost every organ.1 Therefore, organ failure (whether 
single or multiple) is a significant contributor to postburn morbidity and mortality. The 
hyper-metabolic and inflammatory postburn response is associated with vast catabolism, 
protein and amino acid degradation, insulin resistance and hyperglycemia, as well as 
lipolysis, all of which can contribute to organ failure, especially the liver.1–3 Inhalation 
injury impairs the respiratory function by damaging the alveolar epithelium; however, is not 
the exclusive cause of respiratory failure.4–6 Renal failure can result from trauma, and 
inappropriate fluid resuscitation.7–9 Cardiac failure postburn can be a result of cardio-
myocyte apoptosis, dilative cardiomyopathy due to over-resuscitation, or cardio-toxic 
agents.1, 10–12 As previously emphasized, intact organ function is essential to recovery from 
severe thermal injury. Therefore, a discrepancy between demand and function exist that 
impairs postburn morbidity and mortality.
Besides the challenge of treating organ failure, at times, it can be very difficult to detect or 
monitor single- or multiple-organ failure (MOF). Several attempts have been made in the 
past to validate established scoring systems such as the DENVER2 criteria in the burn 
patient population.13 This patient population is at a high risk of developing organ failure and 
would benefit from accurate assessment of organ functions. The DENVER2 score monitors 
the cardiac, respiratory, renal, and liver function of the body.14 Unlike other scoring 
systems, it can be applied to patients of any age and weight, as the quantified parameters are 
consistent in all patient populations. The validity and predictive value of the assessment of 
organ function with other scoring systems has been controversial especially in the burn 
patient population. Due to the physiologic changes in the body and treatment requirements 
such as high-fluid resuscitation, the accuracy of the scoring assessment has been questioned 
by several studies. However, others and we15 hypothesize that the DENVER2 score 
represents an adequate method for screening and monitoring organ failure.
Despite the need to monitor and detect organ failure in burns, to date, there are only few 
studies looking at the incidence of single or MOF. Therefore, the first aim of this study was 
to determine the incidence of organ failure and to identify the critical time points for organ 
specific disorders following severe burn injury during acute hospitalization. Secondly, we 
Kraft et al. Page 2













analyzed the incidence of organ failure and correlated organ failure with the outcome of 
each organ failure or the combination of multiple organs.
PATIENTS AND METHODS
Eight-hundred twenty-one pediatric patients with burns over 30% total burn surface area 
(TBSA) admitted to our burn center were included in the study. Organ function or MOF was 
and is one of the main outcomes of our studies. Therefore, this study is not a retrospective 
analysis; it is a prospective ongoing study with prospective analysis.
In a first assignment, patients were grouped according the incidence of MOF in non-MOF 
and MOF groups using the DENVER2 criteria as described below. To determine the effects 
of specific organ failure, patients were assigned to groups according the occurrence of 
specific organ failures utilizing the same score system. Organ failure was determined in 
patients having a score according the DENVER2 definitions greater than two for each organ.
On admission, patients were resuscitated according to the Galveston formula with 5000 
cc/m2 TBSA burned+2000 cc/m2 TBSA lactated Ringer’s solution given in increments over 
the first 24 hours. Within 48 hours of admission, all patients underwent total burn wound 
excision and the wounds were covered with autograft. Any remaining open areas were 
covered with homograft. This was repeated until all open wound areas were covered with 
autologous skin.
All patients underwent the same nutritional treatment according to a standardized protocol 
as previously published.1, 16, 17 The nutritional route of choice in our patient population was 
enteral nutrition via a naso-duodenal or naso-gastric tube. Parenteral nutrition was only 
given in rare instances if the patient could not tolerate enteral feeds.
Patient demographics (age, date of burn and admission, sex, burn size, and depth of burn) 
and concomitant injuries such as inhalation injury, sepsis, morbidity, and mortality were 
recorded. Sepsis was defined as previously published.1, 16, 17
Organ failure was assessed using the DENVER2 definitions (Supplemental Tables S1, S2) 
prospectively during the entire acute hospital stay. Organ-specific functions were assessed 
continuously during the hospitalization. MOF was set as a total score >3 out of 12 maximum 
points for two or more organs for a minimum of two consecutive days. The worst daily score 
was used to assess the organ failure. Severe organ failure for a single organ was set at >2 
points out of three maximum points of the daily average of the assessed organ DENVER2 
score (Supplemental Tables S1, S2). We further determined time between operations as a 
measure for wound healing/re-epithelization.
Proteins and cytokines
Blood and/or urine was collected from burn patients at admission, pre-operatively, and 5 
days postoperatively for 4 weeks for serum hormone, protein, cytokine and urine hormone 
analysis. Blood was drawn in a serum-separator collection tube and centrifuged for 10 
minutes at 1320 rpm. The serum was removed and stored at −70°C until assayed.
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Serum hormones and acute phase proteins were determined using HPLC, nephelometry 
(BNII, Plasma Protein Analyzer Dade Behring, MD), and ELISA techniques. The Bio-Plex 
Human Cytokine 17-Plex panel was used with the Bio-Plex Suspension Array System (Bio-
Rad, Hercules, CA) to profile expression of seventeen inflammatory mediators as previously 
published.1
Patient data was collected and recorded prospectively using the clinical information system 
Emtek by physicians, nurses and supportive staff. Data was processed and analyzed with 
Microsoft Access®, Excel® Microsoft Corporation Inc. (Redmond, WA, USA).
Ethics and statistics
The study was reviewed and approved by the Institutional Ethics Review Board of the 
University of Texas Medical Branch, Galveston, Texas. Prior to the study, each subject, 
parent or child’s legal guardian had to sign a written informed consent form. Statistical 
methods such as Student’s t-test, Chi-square test, logistic regression and Kaplan-Meier 
Survival Analysis (log-Rank) were used where appropriate. Data are expressed as means
±SD or SEM, where appropriate. Statistical significance was accepted at p<0.05. 
Participating patients were part of a study registered at www.clinicaltrials.gov 
#NCT00673309.
RESULTS
Demographics and clinical outcomes of non-MOF vs. MOF patients
A total of 821 burn patients were included in the study. MOF occurred in 157 burn patients 
while 664 burn patients did not develop MOF during the hospital stay. Both patient 
populations were similar in demographics and did not show significant differences in 
gender, ethnicity, and age (Table 1). Burn size was significantly greater in patients 
developing MOF when compared to patients with no MOF (non-MOF: 51±16 % TBSA, 
MOF: 69±18%, p<0.00001); in addition, full thickness burn was greater in MOF patients 
compared to non- MOF patients (non-MOF: 34±24%, MOF: 58±27%, p<0.00001). 
Furthermore, the incidence of inhalation injury was significantly higher in MOF patients 
compared to non-MOF (non- MOF: 192 (29%), MOF: 89 (57%), p<0.00001). Time injury to 
admission to the burn center did not differ among the groups (non-MOF: 3.6±4.3, MOF 
3.3±4.0, p=0.4).
Overall, patients that developed MOF had significantly worse outcomes compared to burn 
patients that did not develop MOF (Table 2). Confirming our stratification, we found that 
burn patients developing MOF had significantly greater maximum DENVER2 scores when 
compared to non-MOF patients (non-MOF: 2.8±1.1, MOF 6.2±1.7, p<0.00001). MOF 
patients needed significantly more surgeries (non-MOF: 3.3±2.5, MOF: 6.3±4.6, 
p<0.00001), however time between surgeries did not differ (non-MOF: 4.8±1.7, MOF: 
4.9±2.3 days, p=0.3). The length of hospital stay (LOS) was longer in the MOF group (non-
MOF: 22.9±18.2, MOF: 44.1±39.3 days, p<0.00001) which was confirmed when LOS was 
normalized to TBSA burn size (non-MOF: 0.4±0.3, MOF: 0.6±0.5 days/%TBSA burn, 
p<0.00001). MOF was associated with a significant increased incidence of major infections 
Kraft et al. Page 4













(non-MOF: 2.1±2.3, MOF 3.3±2.7, p<0.00001) and Sepsis (non-MOF: 30 (5%), MOF 49 
(31%), p<0.00001). All these worse outcomes are associated with a significantly higher 
mortality (non-MOF: 15 (2%), MOF 65 (41%), p<0.00001).
Kaplan-Meier survival analysis showed that the mortality rate had no peak but was rather 
constant during the first 60 days after burn injury (Figure 1).
Biochemical markers
In order to obtain further insights, we conducted some biochemical analyses. Both patient 
populations - non-MOF and MOF - showed elevated systemic glucose levels (Figure 2). In 
patients with MOF glucose levels were significantly more elevated along the hospital course 
and reached similar levels around day 50 postburn. Inflammatory markers followed the same 
pattern (Figure 3). IL-6 and CRP had a significantly higher expression over the first 60 days. 
MCP-1 and TNF-α assimilated beginning day 41.
Patients grouped according to specific organ failure demographics and outcome 
parameters
The next step was to analyze morbidity and mortality in relation to each single organ failure. 
We found that 586 patients had no evidence of severe organ failure according to the 
definition of the DENVER2 scoring system. Respiratory failure occurred in 230 patients, 
followed by cardiac (n=77), hepatic (n=23), and renal (n=16) failure. Demographics, injury 
characteristics, and clinical outcomes of each patient group were compared to patients with 
no organ failure and shown in Tables 3 and 4. For clarification, some patients had two or 
more organ failure, but were listed for each organ failure hence the sum of the patients is not 
821. All groups were similar in gender distribution (p=0.9) as well as ethnicity distribution. 
Patients with renal failure were significantly older compared to patients without any organ 
dysfunction (no Organ: 7.1±5.3 years, Kidney: 15.3±2.4 years, p=0.0002). TBSA and third-
degree burn size were significantly larger in all organ failure groups compared to the no 
organ failure group (p<0.00001), combined with a higher incidence of flame burn 
(p<0.00001). The largest burn size was found in the renal failure group. Interestingly, 
Inhalation injury did not significantly differ between groups (p=0.1).
All major clinical outcome parameters for each organ failure are shown in Table 4. It is 
interesting to note that the majority of patients detected via DENVER2 scoring had 
pulmonary failure, followed by heart, liver, and lastly kidney. This is most likely due to the 
scoring system that only identifies severe organ damage and hence mild episodes of renal 
failure or liver failure are not detected. Patients with liver failure required the most 
surgeries, while patients with kidney failure or liver failure had the longest LOS even when 
normalized for burn size. Patients with kidney or liver failure had the highest DENVER2 
scores followed by cardiac and lung indicating that these patients were the sickest patients, 
which is reflected in the sepsis and major infection incidence.
Sixty-day mortality was the highest in patients with severe kidney failure, followed by liver 
failure. The best outcome was in burn patients who suffered from pulmonary failure (Figure 
4).
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Co-incidence of organ failure
Causal relationships of the co-incidence of individual organ failures are shown in Table 5A. 
A significant relationship was found in patients with liver failure and consecutive incidence 
of heart and liver failure. Also patients with cardiac failure had a significant interrelation 
with the incidence of liver failure. The primary incidence of respiratory and renal failure did 
not show a statistically significant co-incidence with other organ dysfunction. The highest 
incidence of a single-organ failure was noted in patients with respiratory failure. All other 
groups had a relatively higher incidence of two or more additional organs failing, whereas 
renal failure did not occur as a single organ failure in the patient population.
Severity of organ dysfunction over time
Figure 5 shows the maximum DENVER2 points for each organ during the first 60 days of 
all patients. Cardiac failure had a high variability; lung failure trended to normalize after the 
initial 10 days and increased again along with the hospitalization. Hepatic function worsened 
in patients with a prolonged hospital stay. Renal function was in most patients not impaired 
as recorded by the DENVER2 score in accordance with the low incidence of severe renal 
failure in the pediatric patient population.
DISCUSSION
Severe burn injury is associated with profound hypermetabolic and catabolic responses. 
Protein catabolism leads not only to a failure of the skin barrier but also to impaired organ 
functions.1 Impaired organ function can result in organ failure or even in MOF, which is one 
of the leading causes of death in the thermally injured patient.18 Despite the common 
occurrence of organ failure in this patient population, there’s incomplete understanding of 
single/MOF. The underlying causes leading to organ failure are not clear but have been 
associated infections and sepsis, open burn wounds, inadequate oxygen delivery and 
extraction, protein degradation, insulin resistance and hyperglycemia, lipolysis, and 
impaired gastrointestinal function with increased bacterial translocation. It thus appears that 
single/MOF in the thermally injured patient is very complex, involving a multi-factorial 
cascade of postburn pathophysiologic sequelae.1, 12, 19
Aims of this study were to determine the incidence of single-organ failure, MOF, the time 
course for organ failure, and the outcomes. We found that 19% of our 821 patients had MOF 
as captured by the DENVER2 score. To our surprise the highest incidence of organ failure 
was pulmonary followed by cardiac, liver, and kidney. The worst outcome was in patients 
with profound kidney or liver failure. The best outcome was in burn patients with pulmonary 
failure. We also found that burn patients with 3 or more organ failure have an extremely 
poor prognosis. There were no survivors in the group with three organ failures. The poorest 
outcome again is associated with kidney and liver and an additional organ failure. These 
data clearly indicate that single/MOF is important contributors to mortality. The results of 
our study now necessitate investigations to determine which patients are at high risk to 
develop organ failure to individualize patient treatment. We believe that early detection of 
patients at high risk for MOF is important and would result in improved outcomes, as 
interventions would be implemented early in course of treatment. To our knowledge, there 
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are several studies that are currently investigating the effect of biomarkers on the early 
detection of MOF.
Manifest and severe renal failure was associated with a high mortality despite recent studies 
showing that renal failure is usually associated with a good outcome.9,20 We found that renal 
failure in association with liver failure resulted in very poor outcomes. The reasons for these 
results are not entirely clear; however, possible explanation is that DENVER2 may only 
detect severe non-reversible renal failure and the milder cases of renal dysfunction/failure 
cannot be determined using this score. This surely leads to the question whether DENVER2 
is a valid and applicable score. The discussion remains about the best score to use in burn 
patients. Our choice of the use of the DENVER2 score was based on its application in 
various multicenter trials indicating applicability and validity in burn patients.
One expects that patients with liver failure would have a very poor prognosis, which was 
confirmed in the present study. Several studies have demonstrated that a bilirubin level 
above 4 mg/dl is an indicator of poor prognosis with associated high morbidity and 
mortality.1, 21 The livers metabolic, inflammatory, acute phase and immune functions play a 
pivotal role in recovery from injury in multiple modulating pleiotropic pathways.1, 2, 21, 22 
The hepatic acute phase response is characterized by an increased production of acute phase 
proteins with a failure to produce constitutive proteins. The shift in hepatic protein synthesis 
leads to physiologic alterations of transport, metabolic and immune functions.1, 2, 22 Our 
data shows that the liver is markedly affected postburn and that the shift of the expression of 
hepatic derived proteins is associated with organ failure. Animal studies have shown that 
burn injury causes a vast alteration in the endoplasmic reticulum (ER) and mitochondria 
with depletion of ER calcium stores leading to hepatocyte apoptosis and intracellular 
inflammation.23, 24 Novel treatments to attenuate these responses may improve liver 
function postburn preventing hepatomegaly and impaired protein synthesis improving 
postburn morbidity and consecutively mortality.
Burn injury induces dramatic cardiac stress indicated by increased cardiac output, stroke 
volume, oxygen consumption, and cardiac index.18, 25, 26 In a recent study by Pereira et 
al.,25 cardiac dysfunction was the main contributor to mortality in patients under four years 
of age. We have further shown that the only physiologic difference between burn sizes 20 to 
40, 40 to 60, 60 to 80, and 80 to 100% TBSA was caused by cardiac dysfunction, which 
increased in proportion to burn size.12 Williams et al.26 have recently shown that these 
alterations do not only persist for a short period of time but that cardiac stress continues to 
be present for up to two to three years postburn. All of this data together along with our 
findings show that cardiac stress is present immediately postburn and persists throughout 
acute hospitalization and up to three years.26 Despite the early and high incidence of cardiac 
failure, cardiac dysfunction is associated with the best outcome; and we further propose that 
attenuating cardiac stress (by for example administration of beta adrenergic antagonists such 
as non-selective β1 and β2 blockers) will improve postburn cardiac oxygenation, reduces 
tachycardia, improves cardiac filling, and pressure leading to an attenuated cardiac stress 
response and cardiac work.
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Postburn pulmonary complications are not only present after inhalation injury. Patients with 
severe burns have inflammatory processes causing acute respiratory distress syndrome and 
pneumonia, which are augmented if inhalation injury is present.4, 6, 27, 28 Our data 
demonstrates that lung injury has one of the best survival probabilities postburn indicating 
that current treatment regimens such as low-tidal volume ventilation, administration of 
nebulized heparin, albuterol, cortisol, epinephrine (if needed), and chest physiotherapy as 
well as mucolysis improve pulmonary ventilation and function. We see this as an example of 
how early intervention for organ failure can successfully change hospital course. We fail to 
do so for kidney, liver, probably pancreas, and the gastrointestinal system.
Newer studies looking at proteomic and genomic profiles can help to determine which 
patients are at risk of developing single/MOF (Glue Grant unpublished findings). We 
believe that once protein(s) or gene(s) are identified, which can direct the treating physicians 
in identifying the patients at risk of developing organ failure; their outcomes can be 
dramatically improved. These novel approaches could shorten hospital length of stay and 
possibly decrease postburn morbidity and mortality. To test whether some biomarkers can 
differentiate MOF from non-MOF, we measured glucose and several cytokines and CRP. 
We found that MOF had significantly higher glucose levels, serum IL-6, MCP-1, TNF, and 
CRP at almost all time points. These markers were not predictive, however, were 
significantly different during hospital course.
Conclusions
The present study is the first large-scale study demonstrating the incidence of single or 
MOF. The general incidence of single or MOF is around 20%. Liver and renal failure had 
the worst outcome, while pulmonary and cardiac have a good prognosis. A combination of 
three or more organ failures is always fatal with no therapeutic success. We hypothesize that 
it is now imperative to develop markers to predict patients at high risk for MOF to improve 
postburn outcomes. We, therefore, would like to emphasize that early detection of organ 
failure and intervention are needed to improve postburn outcomes.
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Figure 1. Survival curve for the first 60 days after injury
The mortality rate in patients without MOF was significantly higher during the acute 
hospitalization. Mortality after day 30 plateaued in the non-MOF group, whereas patients 
with MOF showed a constant mortality rate till day 60.
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Daily average glucose levels, an indicator for stress induced insulin resistance and metabolic 
dysfunction is associated with the incidence of MOF. Significantly higher systemic glucose 
levels can be seen in patients with incidence of MOF.
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Biochemical markers for inflammation such as IL-6, MCP-1, TNF-α, and CRP compared 
between the MOF and non-MOF group.
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Survival curve of patients stratified according specific organ failure.
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Average of DENVER2 points over time for the first 60 days after burn injury of all patients. 
Respiratory failure tends to decrease after within the first 10 days after injury whereas liver 
failure has an increasing trend over the first 60 days. Renal and cardiac dysfunction remain 
at relatively stable along the hospital course.
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Table 1
Demographic characteristics at hospital admission.
no MOF MOF p value
n 664 157
Gender
Male (n) 436 95 0.26185
Female (n) 228 62
Ethnicity
African American (n) 53 8 0.14147
Caucasian (n) 111 21
Hispanic (n) 487 123
Other 13 5
Age at admit (years) 7.3 ± 5.2 8.0 ± 5.8
Inhalation Injury n (%) 192 (29) 89 (57) <0.00001
Type of burn
Flame n (%) 444 (67) 124 (79.0) 0.016
Scald n (%) 166 (25) 25 (16)
Other n (%) 54 (8) 8 (5)
TBSA burn % 51 ± 16 69 ± 18 <0.00001
TBSA third % 34 ± 24 58 ± 27 <0.00001
Burn to admit (days) 3.6 ± 4.3 3.3 ± 4.0 0.38695
Patients are stratified according the incidence of MOF. Patients with MOF had a larger burn size and a higher incidence of inhalation injury.
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Table 2
Clinical outcomes and hospital course.
no MOF MOF p value
n 664 157
Max DENVER2 2.8 ± 1.1 6.2 ± 1.7 <0.00001
OR n 3.3 ± 2.5 6.3 ± 4.6 <0.00001
Time between OR (days) 4.8 ± 1.7 4.9 ± 2.3 0.3
LOS ICU (days) 23 ± 18 44 ± 39 <0.00001
LOS/TBSA (days/%) 0.4 ± 0.3 0.6 ± 0.5 <0.00001
MOF n (%) 0 (0) 157 (100) <0.00001
Sepsis n (%) 30 (5) 49 (31) <0.00001
Major infections n 2.1 ± 2.3 3.3 ± 2.7 <0.00001
Mortality n (%) 15 (2) 65 (41) <0.00001
All major clinical outcome parameters showed impaired in the MOF group. The indicator for wound healing (time between the operations) did not 
significantly differ between groups.
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Table 5
Coincidence and correlation between organ failures.
(A)
Heart Lung Kidney Liver
Heart (77) NN 73 10 16*
Lung (230) 73 NN 16 22
Kidney (16) 10 16 NN 6
Liver (23) 16* 22 6* NN
(B)
1 Organ 2 Organs 3 Organs 4 Organs
Heart (77) 4 51 18 4
Lung (230) 147 59 20 4
Kidney (16) 0 4 8 4
Liver (23) 1 4 14 4
(A) Displays the coincidence of the single organ failures. Logistic regression revealed a statistically significant relationship between liver failure 
accompanied by heart and renal failure. (B) Depicts the incidence of single and combined organ failures in the patient population.
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